Stay updated on Propranolol and Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Propranolol and Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Propranolol and Pembrolizumab in Melanoma Clinical Trial page
- Check3 days agoChange DetectedThe page now lists revision v3.3.4, replacing the previous v3.3.3 revision at the bottom of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedAdded a consolidated Locations section listing Georgia, New York, Ohio, and Pennsylvania, and removed the separate Georgia Locations, New York Locations, Ohio Locations, and Pennsylvania Locations subsections.SummaryDifference0.5%

- Check46 days agoChange DetectedFooter revision updated from v3.3.1 to v3.3.2; no study details, navigation, or content were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check53 days agoChange DetectedPage revision history updated from v3.2.0 to v3.3.1; no changes to trial information or study details are evident.SummaryDifference0.1%

- Check61 days agoChange DetectedThe government funding notice banner warning about potential data updates and processing delays has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check75 days agoChange DetectedThe updates seem to be minor formatting/structure changes that do not affect core study details or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Propranolol and Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Propranolol and Pembrolizumab in Melanoma Clinical Trial page.